No consistent definition exists for energy products in the United States. These products have been marketed and sold as beverages (conventional foods), energy shots (dietary supplements), and in pill or tablet form. Recently, the number of available products has surged, and formulations have changed to include caffeine. To help characterize the use of caffeine-containing energy products in the United States, three sources of data were analyzed: sales data, data from federal sources, and reports from the Drug Abuse Warning Network. These data indicate that sales of caffeine-containing energy products and emergency room visits involving their consumption appear to be increasing over time. Data from the National Health and Nutrition Examination Survey (NHANES) 2007-2010 indicate that 2.7% [standard error (SE) 0.2%] of the US population ≥1 year of age used a caffeine-containing energy product, providing approximately 150-200 mg/day of caffeine per day in addition to caffeine from traditional sources like coffee, tea, and colas. The highest usage of these products was among males between the ages of 19 and 30 years (7.6%, SE 1.0). Although the prevalence of caffeine-containing energy product use remains low overall in the US population, certain subgroups appear to be using these products in larger amounts. Several challenges remain in determining the level of caffeine exposure from and accurate usage patterns of caffeine-containing energy products.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658518 | PMC |
http://dx.doi.org/10.1111/nure.12138 | DOI Listing |
Anaesthesiologie
December 2024
Klinik für Intensivmedizin, Gemeinschaftsklinikum Mittelrhein gGmbH, Evangelisches Stift St. Martin, Akademisches Lehrkrankenhaus der Johannes Gutenberg-Universität Mainz, Johannes Müller-Straße 7, 56068, Koblenz, Deutschland.
Medicina (Kaunas)
September 2024
Department of Pharmacology and Public Health, Faculty of Medicine, The Hashemite University, Zarqa 13133, Jordan.
Nonsteroidal anti-inflammatory drugs (NSAIDs) and caffeine-containing beverages are widely consumed but their impact on gastrointestinal (GI) health requires further investigation. This cross-sectional study investigated the relationship between NSAIDs use, caffeinated drink consumption, and the prevalence of self-reported GI symptoms in a Jordanian subpopulation. An online survey was administered to 400 Jordanian individuals aged 18-65 years.
View Article and Find Full Text PDFKorean J Med Educ
September 2024
Department of Urology, Yeungnam University College of Medicine, Daegu, Korea.
Purpose: To investigate the form and level of daily caffeine intake recommended above 400 mg in medical students expected to consume caffeinated beverages to enhance their performance.
Methods: From May to June 2023, freshman through senior medical students at a medical school in Korea were administered a seven-item questionnaire designed to measure the amount of caffeine-containing foods consumed, the weekly interval between consumption, the reason for consumption, and the level of caffeine-induced symptoms experienced.
Results: Out of 443 students, 361 responded (81.
J Anal Toxicol
October 2024
Toxicological Services, NMS Labs, 200 Welsh Rd, Horsham, PA 19044, United States.
ACS Omega
January 2024
Department of Chemistry, Faculty of Science, Mahidol University, Salaya 73170, Nakhon Pathom, Thailand.
This study employs a low-energy emulsification method to prepare caffeine-containing emulsions, denoted as Caf-EM. Three different oils, including coconut, sesame, and grape seed oils, are utilized along with the surfactants Span 80 and Tween 80. We investigate the influence of various factors, including (i) the hydrophilic-lipophilic balance (HLB) and surfactant ratio, (ii) the chemical composition of the oils, and (iii) the presence of caffeine, on the stability and size of emulsions.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!